Unit
Division of Infectious Diseases, Infection Prevention and Travel Medicine
INFEKT · Dept. I
Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy
Bertschy S, Furrer H, Christen A, Chave J, Flepp M, Schmid P, Schiffer V, Bernasconi E, Cavassini M, Opravil M, Swiss HIV Cohort Study. Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006; 12:666-71.
Jul 1, 2006Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy
Jul 1, 2006Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006; 12:666-71
Bertschy S, Furrer H, Christen A, Chave J-P, Flepp M, Schmid Patrick, Schiffer V, Bernasconi E, Cavassini M, Opravil M, Swiss HIV Cohort Study
Stable virulence levels in the HIV epidemic of Switzerland over two decades
Müller V, Bonhoeffer S, Günthard H, Vernazza P, Bernasconi E, Telenti A, Furrer H, Klimkait T, Perrin L, Ledergerber B, Swiss HIV Cohort Study. Stable virulence levels in the HIV epidemic of Switzerland over two decades. AIDS (London, England) 2006; 20:889-94.
Apr 4, 2006Stable virulence levels in the HIV epidemic of Switzerland over two decades
Apr 4, 2006AIDS (London, England) 2006; 20:889-94
Müller Viktor, Bonhoeffer Sebastian, Günthard Huldrych F, Vernazza Pietro, Bernasconi Enos, Telenti Amalio, Furrer Hansjakob, Klimkait Thomas, Perrin Luc, Ledergerber Bruno, Swiss HIV Cohort Study
Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study
Glass T, Battegay M, Hirschel B, Cavassini M, Bernasconi E, Furrer H, Rickenbach M, Vernazza P, Weber R, De Geest S, Bucher H. Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study. Journal of acquired immune deficiency syndromes (1999) 2006; 41:385-92.
Mar 1, 2006Correlates of self-reported nonadherence to antiretroviral therapy in HIV-infected patients: the Swiss HIV Cohort Study
Mar 1, 2006Journal of acquired immune deficiency syndromes (1999) 2006; 41:385-92
Glass Tracy R, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Vernazza Pietro, Weber Rainer, De Geest Sabina, Bucher Heiner C
HIV-discordant couples and parenthood: how are we dealing with the risk of transmission?
Vernazza P, Hollander L, Semprini A, Anderson D, Duerr A. HIV-discordant couples and parenthood: how are we dealing with the risk of transmission?. AIDS (London, England) 2006; 20:635-6.
Feb 28, 2006HIV-discordant couples and parenthood: how are we dealing with the risk of transmission?
Feb 28, 2006AIDS (London, England) 2006; 20:635-6
Vernazza Pietro, Hollander Lital, Semprini Augusto E, Anderson Deborah J, Duerr Ann
[Pneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review]
Bertisch B, Ruef C. [Pneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review]. Z Rheumatol 2006; 65:18-20, 22-3.
Feb 1, 2006[Pneumocystis jiroveci pneumonia (PcP) in patients with rheumatic diseases: case report and review]
Feb 1, 2006Z Rheumatol 2006; 65:18-20, 22-3
Bertisch Barbara, Ruef C
Varizellenpneumonie
Templeton A, Engeler S, Boggian K. Varizellenpneumonie. Schweiz Med Forum 2006; 6
Jan 1, 2006Varizellenpneumonie
Jan 1, 2006Schweiz Med Forum 2006; 6
Templeton Arnoud, Engeler Stephan, Boggian Katia
Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study
Zinkernagel A, Weber R, Schmid P, Bernasconi E, Opravil M, Tarr P, Hirschel B, Battegay M, Furrer H, Rickenbach M, Ledergerber B, von Wyl V, Swiss HIV Cohort Study. Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study. Antiviral therapy 2006; 11:131-42.
Jan 1, 2006Eligibility for and outcome of hepatitis C treatment of HIV-coinfected individuals in clinical practice: the Swiss HIV cohort study
Jan 1, 2006Antiviral therapy 2006; 11:131-42
Zinkernagel Annelies S, Weber Rainer, Schmid Patrick, Bernasconi Enos, Opravil Milos, Tarr Philip E, Hirschel Bernard, Battegay Manuel, Furrer Hansjakob, Rickenbach Martin, Ledergerber Bruno, von Wyl Viktor, Swiss HIV Cohort Study
A smoking cessation programme in HIV-infected individuals: a pilot study
Elzi L, Spoerl D, Voggensperger J, Nicca D, Simcock M, Bucher H, Spirig R, Battegay M, Swiss HIV Cohort Study. A smoking cessation programme in HIV-infected individuals: a pilot study. Antiviral therapy 2006; 11:787-95.
Jan 1, 2006A smoking cessation programme in HIV-infected individuals: a pilot study
Jan 1, 2006Antiviral therapy 2006; 11:787-95
Elzi Luigia, Spoerl David, Voggensperger Jacqueline, Nicca Dunja, Simcock Mathew, Bucher Heiner C, Spirig Rebecca, Battegay Manuel, Swiss HIV Cohort Study
Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
Karrer U, Speck R, Weber R, Russotti M, Schmid P, Hirschel B, Gayet-Ageron A, Cavassini M, Battegay M, Elzi L, Furrer H, Ledergerber B, Swiss HIV Cohort Study. Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir. AIDS (London, England) 2005; 19:1987-94.
Nov 18, 2005Dose-dependent influence of didanosine on immune recovery in HIV-infected patients treated with tenofovir
Nov 18, 2005AIDS (London, England) 2005; 19:1987-94
Karrer Urs, Speck Roberto F, Weber Rainer, Russotti Marina, Schmid Patrick, Hirschel Bernard, Gayet-Ageron Angèle, Cavassini Matthias, Battegay Manuel, Elzi Luigia, Furrer Hansjakob, Ledergerber Bruno, Swiss HIV Cohort Study
Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy
Wunder D, Furrer H, Schmid P, Schiffer V, Bucher H, Cavassini M, Bernasconi E, Weber R, Fux C, Bersinger N, Swiss HIV Cohort Study. Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy. AIDS (London, England) 2005; 19:1837-42.
Nov 4, 2005Plasma leptin levels in men are not related to the development of lipoatrophy during antiretroviral therapy
Nov 4, 2005AIDS (London, England) 2005; 19:1837-42
Wunder Dorothea, Furrer Hansjakob, Schmid Patrick, Schiffer Véronique, Bucher Heiner C, Cavassini Matthias, Bernasconi Enos, Weber Rainer, Fux Christoph, Bersinger Nick A, Swiss HIV Cohort Study
HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss
Schüpbach J, Hirschel B, Bernasconi E, Vernazza P, Furrer H, Battegay M, Perrin L, Yerly S, Tomasik Z, Böni J, Fischer M, Joos B, Günthard H, Swiss HIV Cohort Study. HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss. Journal of acquired immune deficiency syndromes (1999) 2005; 40:250-6.
Nov 1, 2005HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss
Nov 1, 2005Journal of acquired immune deficiency syndromes (1999) 2005; 40:250-6
Schüpbach Jörg, Hirschel Bernard, Bernasconi Enos, Vernazza Pietro, Furrer Hansjakob, Battegay Manuel, Perrin Luc, Yerly Sabine, Tomasik Zuzana, Böni Jürg, Fischer Marek, Joos Beda, Günthard Huldrych, Swiss HIV Cohort Study
Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial
Tillmann H, Lundgren J, Dragsted U, Hill A, Vernazza P, Monforte A, Antunes F, Staszewski S, Fox Z, Kaiser T, MaxCmin1 Trial Group. Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial. Journal of acquired immune deficiency syndromes (1999) 2005; 40:378-80.
Nov 1, 2005Impact of coinfection with HIV-1 and GB virus C in patients receiving a ritonavir-boosted HAART regimen: a substudy to the MaxCmin1 trial
Nov 1, 2005Journal of acquired immune deficiency syndromes (1999) 2005; 40:378-80
Tillmann Hans L, Lundgren Jens D, Dragsted Ulrik B, Hill Andrew, Vernazza Pietro, Monforte Antonella d'Arminio, Antunes Francesco, Staszewski Schlomo, Fox Zoe, Kaiser Thorsten, MaxCmin1 Trial Group
Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia
Rotger M, Telenti A, Rickenbach M, Bernasconi E, Drechsler H, Vernazza P, Furrer H, Günthard H, Bleiber G, Taffé P, Swiss HIV Cohort Study. Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia. The Journal of infectious diseases 2005; 192:1381-6.
Oct 15, 2005Gilbert syndrome and the development of antiretroviral therapy-associated hyperbilirubinemia
Oct 15, 2005The Journal of infectious diseases 2005; 192:1381-6
Rotger Margalida, Telenti Amalio, Rickenbach Martin, Bernasconi Enos, Drechsler Henning, Vernazza Pietro, Furrer Hansjakob, Günthard Huldrych F, Bleiber Gabriela, Taffé Patrick, Swiss HIV Cohort Study
Swollen leg with blisters
Rafeiner P, Templeton A, Vonesch H. Swollen leg with blisters. Praxis 2005; 94:1569-74.
Oct 5, 2005Swollen leg with blisters
Oct 5, 2005Praxis 2005; 94:1569-74
Rafeiner Philippe, Templeton Arnoud, Vonesch H J
[Ready for antiretroviral therapy? Therapy decision making experiences of persons living with HIV]
Nicca D, Fehr J, Battegay M, Spirig R. [Ready for antiretroviral therapy? Therapy decision making experiences of persons living with HIV]. Pflege 2005; 18:289-98.
Oct 1, 2005[Ready for antiretroviral therapy? Therapy decision making experiences of persons living with HIV]
Oct 1, 2005Pflege 2005; 18:289-98
Nicca Dunja, Fehr Jan, Battegay Manuel, Spirig Rebecca
Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients
Ferguson N, Mayer S, Lapins D, Vernazza P, Rode R, Bartley L, Fraser C, Ghani A, Hooper J, Donnelly C, Anderson R. Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients. Journal of the Royal Society, Interface / the Royal Society 2005; 2:349-63.
Sep 22, 2005Adherence to antiretroviral therapy and its impact on clinical outcome in HIV-infected patients
Sep 22, 2005Journal of the Royal Society, Interface / the Royal Society 2005; 2:349-63
Ferguson N M, Mayer S L, Lapins D, Vernazza Pietro, Rode R A, Bartley L M, Fraser C, Ghani A C, Hooper J, Donnelly C A, Anderson R M
Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
Kaufmann G, Battegay M, Hirschel B, Rickenbach M, Bernasconi E, Cavassini M, Vernazza P, Opravil M, Perrin L, Ledergerber B, Furrer H, Swiss HIV Cohort Study. Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:361-72.
Aug 1, 2005Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy
Aug 1, 2005Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:361-72
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Rickenbach Martin, Bernasconi Enos, Cavassini Matthias, Vernazza Pietro, Opravil Milos, Perrin Luc, Ledergerber Bruno, Furrer Hansjakob, Swiss HIV Cohort Study
Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study
Rauch A, Furrer H, Evison J, Zinkernagel A, Bernasconi E, Vernazza P, Bucher H, Tarr P, Hirschel B, Weber R, Rickenbach M, Swiss HIV Cohort Study. Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:395-402.
Aug 1, 2005Unsafe sex and increased incidence of hepatitis C virus infection among HIV-infected men who have sex with men: the Swiss HIV Cohort Study
Aug 1, 2005Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005; 41:395-402
Rauch Andri, Furrer Hansjakob, Evison John, Zinkernagel Annelies S, Bernasconi Enos, Vernazza Pietro, Bucher Heiner C, Tarr Philip E, Hirschel Bernard, Weber Rainer, Rickenbach Martin, Swiss HIV Cohort Study
Starting or changing therapy - a prospective study exploring antiretroviral decision-making
Fehr J, Battegay M, Spirig R, Jäger H, Vernazza P, Bregenzer T, Kiss A, Wagels T, Wolf E, Sendi P, Nicca D, Swiss HIV Cohort Study. Starting or changing therapy - a prospective study exploring antiretroviral decision-making. Infection 2005; 33:249-56.
Aug 1, 2005Starting or changing therapy - a prospective study exploring antiretroviral decision-making
Aug 1, 2005Infection 2005; 33:249-56
Fehr J S, Battegay M, Spirig R, Jäger H, Vernazza Pietro, Bregenzer T, Kiss A, Wagels T, Wolf E, Sendi P, Nicca D, Swiss HIV Cohort Study
Perturbare humanum est! – Accuracy of pharmaceutical advertisements
Hoffmann M, Hoess C (2005). Perturbare humanum est! – Accuracy of pharmaceutical advertisements.
May 25, 2005Perturbare humanum est! – Accuracy of pharmaceutical advertisements
May 25, 200573th annual assembly of the Swiss Society of Internal Medicine (SGIM)
Hoffmann Matthias, Hoess Claus